Bringing the fundamentals into focus…
Back to Ascendis Pharma A/S
How Ascendis Pharma A/S stacks up
ASND · against 123 other Healthcare companies of similar size
Growth
96/ 100
Near the top of its peers.
Ranked #5 of 124 · scores higher than 96% of peers
Bars: peers in each 10-point band of the growth score14 peers with a growth score of 90–100, including ASND · Click a bar to see the companies
Why growth scores 96?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 95% of peers. Revenue growth: 98.0% vs peer median 6.1%
- faster revenue growth over three years: stronger than 98% of peers. 3-year revenue growth: 141.4% vs peer median 5.8%
Metric by metric
Position: dot = ASND, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ASND | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 125 reported | 98.0% | 9.9% | 94% | 33% | |
| Earnings per share growthHigher is better · 92 reported | Not reported | 18.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 120 reported | 141.4% | 10.7% | 97% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ASND| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 21.4B USD | 97 | 67 | |
| 5 | 16.5B USD | 96 | 37 | |
| 5 | 14.5B USD | 96 | 30 | |
| 7 | 9.0B USD | 95 | 51 | |
| 7 | 22.8B USD | 95 | 38 | |
| 9 | 71.0B HKD (≈$9.1B) | 94 | 54 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score